Shifting Sands in Biotech: Apriori Bio’s Strategic Pivot Amid Workforce Reductions
Amid a biotech landscape in flux, Apriori Bio shifts focus, reducing its workforce by 15 to enhance vaccine development. The company transitions from platform expansion to accelerating its pipeline, leveraging…